Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Melanoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1Brain Neoplasms 1

Interventions

Transcranial Direct Current Stimulation 4Walking 2lime 1Ultraviolet Therapy 1Tai Ji 1Sugars 1Standard of Care 1Sodium Chloride 1Silymarin 1Organization and Administration 1Methylphenidate 1Memantine 1Low-Level Light Therapy 1G(M1) Ganglioside 1Equine-Assisted Therapy 1Drug Therapy 1Donepezil 1Docosahexaenoic Acids 1Cognitive Training 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Memantine × Breast × Clear all
NCT06727773 2026-05-06

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡